The report "Europe Artificial Intelligence (AI) in Healthcare Market by Offering (Integrated), Function (Diagnosis, Genomic, Precision Medicine, Radiation, Telehealth, RPM, Immunotherapy, Supply Chain), Application (Clinical), End User (Hospitals) - Forecast to 2030" is projected to grow from USD 6.12 billion in 2025 and to reach USD 31.72 billion by 2030, at a Compound Annual Growth Rate (CAGR) of 39.0% during the forecast period.
Browse 378 market data Tables and 48 Figures spread through 438 Pages and in-depth TOC on "Europe Artificial Intelligence (AI) in Healthcare Market by Offering (Integrated), Function (Diagnosis, Genomic, Precision Medicine, Radiation, Telehealth, RPM, Immunotherapy, Supply Chain), Application (Clinical), End User (Hospitals) - Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/europe-ai-in-healthcare-market-157147048.html
The growing demand for early detection and diagnosis, exponential growth in healthcare data driven by generalized digitalization, and increasing cost pressures on European healthcare systems propelled by growing aging populations and chronic disease burden are some of the important factors driving the growth of the Europe artificial intelligence (Al) in healthcare market. The rapid proliferation of Al-enabled clinical and operational solutions, along with strong government support for digital transformation, is further accelerating the adoption as health systems look to attain higher quality of care, efficiency, and optimization of scarce resources.
However, there are a number of factors continuing to restrain growth in Europe, including resistance from some clinicians to move toward AI-driven technologies and a lack of fully harmonized standards and frameworks for AI and machine learning across the continent. Compliance with GDPR and evolving regulations, including the EU AI Act, further complicate matters, demanding robust governance structures and slowing deployment in some markets.
By tool, the deep learning subsegment held the largest market share of the Europe artificial intelligence (AI) in healthcare market for machine learning in 2024.
By tool, the Europe artificial intelligence (Al) in healthcare market for machine learning is bifurcated into deep learning, supervised learning, reinforcement learning, unsupervised learning, and other machine learning technologies. The deep learning segment accounted for the largest share of the Europe AI in healthcare market in 2024, driven by its strong ability to analyze large volumes of unstructured medical data such as electronic health records (EHRs), medical imaging, and genomics generated across European healthcare systems. These capabilities enable highly accurate disease diagnosis, early detection and personalized treatment planning.
The integration of deep learning into European healthcare workflows is significantly boosting market growth, supported by major investments in diagnostic imaging Al, predictive analytics, and clinical decision support tools. As computational power grows and cross-border data availability increases through initiatives such as the European Health Data Space (EHDS), deep learning is expected to accelerate further innovation. This positions deep learning as a foundational enabler of next-generation healthcare technologies across Europe.
By end user, healthcare providers held the largest market share of the Europe artificial intelligence (AI) in healthcare market in 2024.
Based on end user, the Europe artificial intelligence (AI) in healthcare market is classified into healthcare providers, healthcare payers, patients, and other end users. Healthcare providers have emerged as a leading segment in the Europe artificial intelligence (AI) in healthcare market in 2024. The major factor contributing to this is the increasing focus placed on improving the quality of healthcare in European healthcare systems. European healthcare providers have initiated spending more of their budget on AI-enabled diagnostic solutions, workflow automation solutions, remote monitoring solutions, and healthcare decision support solutions with an ultimate goal of lowered healthcare expenditures and fast and quality patient treatment.
The UK is expected to experience considerable growth from 2025 to 2030.
Based on country, the Europe artificial intelligence (AI) in healthcare market is divided into Germany, France, the UK, Italy, Spain, and the Rest of Europe. Among these, the UK market is expected to register the highest growth rate over the forecast period. The increasing adoption of AI in diagnostics and workflow solutions in healthcare by the NHS in a matter of months, in addition to a unified European initiative to promote AI at a fast pace in Europe, will see this market register a fast pace of AI adoption. The European initiative of a European Health Data Space (EHDS) is bringing in a common platform with regards to securing secondary usage in healthcare, which, in turn, will lead to a better usage of AI models in Europe. Additionally, the very high level of regulatory guidelines with regards to AI in healthcare in Europe with the EU AI Act will have a positive impact in increasing investor sentiments in deploying ‘Safe AI in healthcare in Europe.’ Furthermore, public spending programs such as "Horizon Europe," “Gen AI4EU,” and “EU4Health,” in addition to advancements in “EuroHPC,” will bring in a fast pace of pilot projects for AI in Europe.
Key Players
The prominent players operating in the Europe artificial intelligence (AI) in healthcare market include Koninklijke Philips N.V. (Netherlands), Microsoft Corporation (US), Siemens Healthineers AG (Germany), NVIDIA Corporation (US), Epic Systems Corporation (US), GE Healthcare (US), Medtronic (US), Oracle (US), Merative (IBM) (US), Google (US), Cognizant (US), Johnson & Johnson (US), and Amazon Web Services, Inc. (US), among others.These companies adopted strategies such as product launches, product updates, expansions, partnerships, collaborations, mergers, and acquisitions to strengthen their market presence in the Europe artificial intelligence (AI) in healthcare market.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/